Broad spectrum antiangiogenic treatment for ocular neovascular diseases - Wikidata - wikimedia - TriplyDB

Broad spectrum antiangiogenic treatment for ocular neovascular diseases

Broad spectrum antiangiogenic treatment for ocular neovascular diseases

http://www.wikidata.org/entity/Q28475373

about

Suppression of experimental choroidal neovascularization by curcumin in mice Suppression of autoimmune retinal inflammation by an antiangiogenic drug Interplay between CCN1 and Wnt5a in endothelial cells and pericytes determines the angiogenic outcome in a model of ischemic retinopathy.γ-Secretase inhibition of murine choroidal neovascularization is associated with reduction of superoxide and proinflammatory cytokines.Suppression and regression of choroidal neovascularization in mice by a novel CCR2 antagonist, INCB3344 The ABCs of RVO: a review of retinal venous occlusion.Modifying Choroidal Neovascularization Development with a Nutritional Supplement in Mice Differentiation/Purification Protocol for Retinal Pigment Epithelium from Mouse Induced Pluripotent Stem Cells as a Research Tool.Natural product inhibitors of ocular angiogenesis.Expression of pro- and anti-angiogenic factors during the formation of the periocular vasculature and development of the avian cornea.

P2860

Q28484654-2DBD1A38-A4F7-471F-8B97-52E9DEA9BB00 Q28533918-F2E8A8B0-87DB-43CF-ACC7-74C4C65CE923 Q33684492-5FB45320-A5D9-4479-887D-01C1D79EC0BC Q34113394-B57D5AC6-DFC0-4A45-B8A2-93402F16FDD6 Q34113663-5DF52C3B-54F7-4085-83F5-E13CACEEE07C Q35047634-EA31F437-0DF2-4F8C-AEBE-7FBB4E25C94B Q35685717-B7378181-2AEB-427B-9CE2-A6800EEF8868 Q36069299-6FB1B329-D842-4A8E-ABB6-783CFCD132F5 Q38258984-DBDE516C-3393-4CEE-943A-EAF5074A0ED9 Q41466827-8E48C4FE-5368-4C58-BB96-12E436A43CE3

P2860

Broad spectrum antiangiogenic treatment for ocular neovascular diseases

http://www.wikidata.org/entity/Q28475373

description

2010 nî lūn-bûn

@nan

2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Broad spectrum antiangiogenic treatment for ocular neovascular diseases

@ast

Broad spectrum antiangiogenic treatment for ocular neovascular diseases

@en

Broad spectrum antiangiogenic treatment for ocular neovascular diseases

@nl

type

label

Broad spectrum antiangiogenic treatment for ocular neovascular diseases

@ast

Broad spectrum antiangiogenic treatment for ocular neovascular diseases

@en

Broad spectrum antiangiogenic treatment for ocular neovascular diseases

@nl

prefLabel

Broad spectrum antiangiogenic treatment for ocular neovascular diseases

@ast

Broad spectrum antiangiogenic treatment for ocular neovascular diseases

@en

Broad spectrum antiangiogenic treatment for ocular neovascular diseases

@nl

P1433

Q28475373-B1035A79-F5BE-4417-8C7A-7B4E69FA1F9B

P1476

Q28475373-5D6A200A-626C-45EB-8030-B2B2DBE11AAB

P2093

Q28475373-12C8CBBE-48DD-47E2-BF7B-4B4F9FFE01DC

Q28475373-1F9A403F-353A-4D45-BA25-0A3B77066F24

Q28475373-6C2B2785-633B-4EC4-874F-B106511CE05D

Q28475373-6E3B7D40-A96F-4228-AEBD-4666355D982A

Q28475373-6F395F22-EBB0-4A32-8417-08EB70114422

Q28475373-71F57DFD-812F-48A9-BA32-CC45DA538AFE

Q28475373-952A92CF-B6CA-426B-A250-B7313751C7B8

Q28475373-B2803DD3-2D2A-40AA-9928-620C55B720A6

Q28475373-C1ECA6D8-B601-459D-9AD4-4D60E7B3FEF4

P2860

Q28475373-00219D80-EA38-48E5-93BF-4037AC4C9608

Q28475373-032A0FC4-227F-40BE-A960-AB1E93346C4D

Q28475373-1F0B2EE1-A41E-4AF7-80EA-5D313A751489

Q28475373-2014768F-229B-4C33-B369-D7F3FC2D2A18

Q28475373-3930B197-426B-4E9C-8C7D-E5D2D07AAE53

Q28475373-3DCAB074-0913-4010-9741-468C52379FB8

Q28475373-45432FB8-EFD8-4D9B-9EA6-D72FACEC688D

Q28475373-5236E793-30C1-48E2-8973-60F6B4E89AE9

Q28475373-53486ED6-4167-4F32-BECB-69B293DD4079

Q28475373-5C8ADCA5-ED62-4A34-A7BB-3EF667A3BBC7

P304

Q28475373-CC9F8FBD-692C-4426-9633-8EAA0C755FC7

P31

Q28475373-7C76CA69-5C61-45B0-B90E-7A5916ED7A1C

P3181

Q28475373-05E88E8F-1F0D-4AFD-B1EE-B76DB792671C

P356

Q28475373-8CD87157-463D-4C66-8E2F-C4B81E60785F

P407

Q28475373-094AC5FC-7D5D-4A52-BA44-1896ACB27243

P433

Q28475373-A2C800C8-D221-4B9C-B829-373C6D908A05

P478

Q28475373-DF207531-38ED-459C-904F-735BFF7506AD

P50

Q28475373-EF521149-3729-4E44-BD8A-68C18C6A71D3

P577

Q28475373-79693BE5-B544-4D6F-95D4-69F51D4A4953

P5875

Q28475373-E29976FD-7E23-47A4-B45A-5E92CFB08ABB

P698

Q28475373-9F663422-9F4B-4B14-9047-AA8964574450

P932

Q28475373-9151B77D-C2BB-4EFD-AB1B-8C531393E5BF

P3181

P356

JOURNAL.PONE.0012515

P1433

P1476

Broad spectrum antiangiogenic treatment for ocular neovascular diseases

@en

P2093

Dipak Panigrahy

http://www.w3.org/2001/XMLSchema#string

James D Akula

http://www.w3.org/2001/XMLSchema#string

Kei Nakai

http://www.w3.org/2001/XMLSchema#string

Lauren Bazinet

http://www.w3.org/2001/XMLSchema#string

Ofra Benny

http://www.w3.org/2001/XMLSchema#string

Pouya Pakneshan

http://www.w3.org/2001/XMLSchema#string

Robert J D'Amato

http://www.w3.org/2001/XMLSchema#string

Shintaro Nakao

http://www.w3.org/2001/XMLSchema#string

Takeru Yoshimura

http://www.w3.org/2001/XMLSchema#string

P2860

An orally delivered small-molecule formulation with antiangiogenic and anticancer activity

Amplification and kinetics of the activation steps in phototransduction

Regulation and function of NF-kappaB transcription factors in the immune system

Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model.

Endogenous endostatin inhibits choroidal neovascularization.

Delayed type hypersensitivity: current theories with an historic perspective.

Ophthalmic drug discovery.

The oscillatory potentials of the dark-adapted electroretinogram in retinopathy of prematurity

The endothelium and vascular inflammation in diabetes.

Enhanced permeability and retention of macromolecular drugs in solid tumors: a royal gate for targeted anticancer nanomedicines.

P304

e12515

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

241808

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0012515

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P50

Ali Hafezi-Moghadam

P577

2010-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

46170850

http://www.w3.org/2001/XMLSchema#string

P698

20824139

http://www.w3.org/2001/XMLSchema#string

P932

2931703

http://www.w3.org/2001/XMLSchema#string